Dendrobine Ameliorates Alzheimer's Disease-like Pathology and Cognitive Decline in 3 × Tg-AD Mice.

Brain Sci

Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563003, China.

Published: February 2024

Previous studies have shown that Lindl. alkaloids (DNLAs) have neuroprotective effects in several Alzheimer's disease (AD) models. Dendrobine (DDB) is one of the monomer components with the highest content in DNLAs. However, the effects of DDB on cognitive impairments in AD remain unknown. In this study, we investigated the efficacy of DDB in 3 × Tg-AD mice to determine whether DDB was a key component of the anti-AD effect of DNLAs. Five-month mice were intragastrically administrated with DDB (10 and 20 mg/kg/d) or DNLAs (20 mg/kg/d) for seven consecutive months, and the effects of DDB and DNLAs were evaluated at twelve months. The results revealed that 3 × Tg-AD mice treated with DDB showed enhanced nesting ability. DDB also effectively rescued spatial learning and memory deficits in 3 × Tg-AD mice. Meanwhile, DDB treatment prevented the loss of dendritic spine density, with increased expression levels of synaptophysin, PSD95, and NCAM in the hippocampus. Finally, DDB ameliorated the increase in APP, sAPPβ, CTF-β, and β-amyloid peptides, accompanied by the promotion of GSK phosphorylation at the Ser9 site, thereby reducing hyperphosphorylated tau levels. As the active component of DNLA, DDB can preserve cognitive function, alleviate neuronal and synaptic defects, and improve APP/tau pathology in 3 × Tg-AD mice.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10968537PMC
http://dx.doi.org/10.3390/brainsci14030231DOI Listing

Publication Analysis

Top Keywords

tg-ad mice
20
ddb
11
effects ddb
8
mice
6
tg-ad
5
dnlas
5
dendrobine ameliorates
4
ameliorates alzheimer's
4
alzheimer's disease-like
4
disease-like pathology
4

Similar Publications

The total withanolides from the leaves of Datura stramonium L. Improves Alzheimer's disease pathology by restraining neuroinflammation through NLRP3/IL-1β/IL1R1/TOM 1 pathway.

Int Immunopharmacol

December 2024

Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, China; Traditional Chinese Medicine (TCM) Biological Genetics (Heilongjiang Province Double First-class Construction Interdiscipline, China. Electronic address:

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the deposition of beta-amyloid (Aβ) peptides. Microglia-mediated neuroinflammation is one of the primary contributors to the pathogenesis of AD. Withanolides, the main constituents in the leaves of Datura stramonium L.

View Article and Find Full Text PDF

Pedunculoside alleviates cognitive deficits and neuronal cell apoptosis by activating the AMPK signaling cascade.

Chin Med

November 2024

Zhejiang TCM Key Laboratory of Pharmacology and Translational Research of Natural Products, School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, 310014, Zhejiang, China.

Background: Mitochondrial dysfunction emerges as an early pathological hallmark of Alzheimer's disease (AD). The reduction in mitochondrial membrane potential and the elevation of reactive oxygen species (ROS) production are pivotal in the initiation of neuronal cell apoptosis. Pedunculoside(Ped), a novel triterpene saponin derived from the dried barks of Ilex rotunda Thunb, exhibits a potent anti-inflammatory effect.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of catecholamines (like dopamine and norepinephrine) in the development of Alzheimer's disease (AD) and vascular dementia (VaD) by analyzing their levels in animal models.
  • Using specific mouse and rat models, researchers measured catecholamine concentrations in both blood and different brain areas to understand their distribution and expression during these neurodegenerative processes.
  • Findings reveal that while catecholamines like dopamine are significant in AD, VaD is more associated with changes in the central noradrenergic system and increased serum catecholamines, suggesting different treatment approaches may be needed for each condition.
View Article and Find Full Text PDF

Akt-activated GSK3β inhibitory peptide effectively blocks tau hyperphosphorylation.

Arch Pharm Res

November 2024

Department of Pharmacy, College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241, Republic of Korea.

Article Synopsis
  • Tau hyperphosphorylation and accumulation in neurofibrillary tangles are linked to cognitive decline in Alzheimer's disease, with GSK3β overexpression playing a key role.
  • A new GSK3β inhibitory peptide (GIP) was developed, combining motifs from LRP6 and a sequence targeting Akt, effectively blocking tau phosphorylation and reducing cell death.
  • In vivo tests on a mouse model showed that GIP reduced tau phosphorylation in the hippocampus, improved memory, and did not affect Aβ plaque levels or neuroinflammation, suggesting a new approach for treating Alzheimer's.
View Article and Find Full Text PDF

Introduction: The prevalence of Alzheimer's disease (AD) is significantly gender-differentiated, with the number of female AD patients far exceeding that of males, accounting for two-thirds of the total prevalence. Although postmenopausal AD mice have been shown to have more prominent pathologic features and memory impairments than normal AD mice, the relevant molecular mechanisms leading to these outcomes have not been well elucidated. In the present study, we used the disturbance of excitation-inhibition balance in the postmenopausal brain as an entry point to explore the link between estrogen deficiency, disorders of the glutamatergic-GABAergic nervous system, and memory impairment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!